Veracyte Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Veracyte Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Veracyte Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Veracyte Inc. is VCYT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Veracyte Inc. has its primary listing on NASDAQ. You can trade Veracyte Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Veracyte Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Veracyte Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Veracyte Inc..